SCHEMBL2937729

SCHEMBL2937729

CS(=O)(=O)c1ccc(Oc2cc[c]cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 6/20 0.47
SMN1; SMN2 Q16637 6/20 0.47
LMNA P02545 5/20 0.47
ALDH1A1 P00352 4/20 0.47
PTGS2 P35354 3/20 0.44
ENPP2 Q13822 1/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
TSHR P16473 1/20 0.42
XBP1 P17861 1/20 0.42
MAPK1 P28482 1/20 0.42
MDM2 Q00987 1/20 0.42
HSD17B10 Q99714 1/20 0.42
POLB P06746 1/20 0.42
SOS1 Q07889 1/20 0.41
PTGS1 P23219 2/20 0.41
SLC6A4 P31645 1/20 0.41
MMP14 P50281 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11547843 0.87 HTT (0.58) HTTSMN1; SMN2LMNAALDH1A1PTGS2
SCHEMBL8941654 0.81 PTGS2 (0.56) HTTSMN1; SMN2LMNAALDH1A1PTGS2
SCHEMBL20194 0.80 ENPP2 (0.50) PTGS2ENPP2
SCHEMBL9153268 0.80 SMN1; SMN2 (0.47) HTTSMN1; SMN2LMNAALDH1A1NPC1
SCHEMBL2758531 0.79 HTT (0.63) HTTSMN1; SMN2LMNAALDH1A1PTGS2
SCHEMBL7359540 0.79 SOS1 (0.64) HTTSMN1; SMN2LMNAPTGS2TSHR
SCHEMBL8005674 0.79 PKM (0.61) PTGS2NPC1RAB9APTGS1
SCHEMBL13814624 0.79 HTT (0.63) HTTSMN1; SMN2LMNAALDH1A1PTGS2
SCHEMBL2894725 0.78 PTGS2 (0.38) HTTSMN1; SMN2LMNAALDH1A1PTGS2
SCHEMBL7363510 0.78 SOS1 (0.66) PTGS2SOS1PTGS1SLC6A4MMP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2220081-A2 GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT LG Life Sciences Ltd. (KR) 2010-08-25 EP disclosed
WO-2009082152-A2 GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT LG LIFE SCIENCES LTD. (KR) 2009-07-02 WO disclosed
CN-100457823-C Epoxy resin composition, cured article obtained from the epoxy resin, and semiconductor device obtained thereof MITSUI CHEMICALS INC (JP) 2009-02-04 CN disclosed
CN-1285636-C Process for producing oxyalkylene derivative MITSUI CHEMICALS INC (JP) 2006-11-22 CN disclosed
CN-1781985-A Epoxy resin composition, cured article obtained from the epoxy resin, and semiconductor device obtained thereof MITSUI CHEMICALS INC (JP) 2006-06-07 CN disclosed
CN-1592764-A Method for producing organic compound, epoxy resin composition, cured product of the epoxy resin, and semiconductor device formed using the epoxy resin MITSUI CHEMICALS INC (JP) 2005-03-09 CN disclosed